The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study-Reference-Cited by-同舟云学术

The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study

Published:2020-10 Issue:8 Volume:8 Page:949-960
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Burisch Johan¹^ORCID,Bergemalm Daniel²,Halfvarson Jonas²,Domislovic Viktor³^ORCID,Krznaric Zeljko³⁴,Goldis Adrian⁵,Dahlerup Jens F⁶,Oksanen Pia⁷⁸,Collin Pekka⁸,Castro Luisa⁹¹⁰,Hernandez Vicent⁹¹⁰,Turcan Svetlana¹¹,Belousova Elena¹²,D’Incà Renata¹³,Sartini Alessandro¹⁴^ORCID,Valpiani Daniela¹⁴,Giannotta Martina¹⁵,Misra Ravi¹⁶,Arebi Naila¹⁶,Duricova Dana¹⁷¹⁸,Bortlik Martin¹⁷¹⁸,Gatt Kelly¹⁹,Ellul Pierre¹⁹,Pedersen Natalia²⁰,Kjeldsen Jens²¹,Andersen Karina W²²,Andersen Vibeke²²²³,Katsanos Konstantinos H²⁴,Christodoulou Dimitrios K²⁴,Sebastian Shaji²⁵²⁶,Barros Luisa²⁷,Magro Fernando²⁷²⁸^ORCID,Midjord Jóngerð MM²⁹,Nielsen Kári R²⁹,Salupere Riina³⁰,Kievit Hendrika AL³¹,Kiudelis Gediminas³²,Kupčinskas Juozas³²³³,Fumery Mathurin³⁴,Gower‐Rousseau Corinne³⁵³⁶,Kaimakliotis Ioannis P³⁷,Schwartz Doron³⁸,Odes Selwyn³⁹,Lakatos Laszlo⁴⁰,Lakatos Peter L⁴¹⁴²,Langholz Ebbe⁴³,Munkholm Pia¹,

Affiliation:

1. Department of GastroenterologyNorth Zealand University HospitalFrederikssundDenmark

2. Department of GastroenterologyÖrebro UniversityÖrebroSweden

3. Department of GastroenterologyHepatology and NutritionUniversity Hospital Centre ZagrebZagrebCroatia

4. School of MedicineUniversity of ZagrebZagrebCroatia

5. Clinic of GastroenterologyUniversity of Medicine ‘Victor Babes’TimisoaraRomania

6. Department of Hepatology and GastroenterologyAarhus University HospitalAarhusDenmark

7. Department of Gastroenterology and Alimentary Tract SurgeryTampere University HospitalTampereFinland

8. Faculty of Medicine and Health TechnologyTampere UniversityTampereFinland

9. Department of GastroenterologyComplexo Hospitalario Universitario de VigoVigoSpain

10. Digestive Diseases Research GroupGalicia Sur Health Research Institute (IIS Galicia Sur)VigoSpain

11. Department of GastroenterologyState University of Medicine and Pharmacy of the Republic of MoldovaChisinauRepublic of Moldova

12. Department of GastroenterologyMoscow Regional Research Clinical InstituteMoscowRussian Federation

13. Department of SurgicalOncological and Gastroenterological SciencesUniversity of PaduaPadovaItaly

14. UO Gastroenterologia ed Endoscopia digestivaHospital Morgagni PierantoniForlìItaly

15. Department of GastroenterologyAzienda USL Toscana CentroFlorenceItaly

16. IBD DepartmentImperial College LondonLondonUK

17. IBD Clinical and Research CentreISCAREPragueCzech Republic

18. Institute of PharmacologyCharles University in PraguePragueCzech Republic

19. Division of GastroenterologyMater Dei HospitalMsidaMalta

20. Gastroenterology DepartmentSlagelse HospitalSlagelseDenmark

21. Gastroenterology DepartmentOdense University HospitalOdenseDenmark

22. IRS‐Center SoenderjyllandUniversity Hospital of Southern DenmarkAabenraaDenmark

23. Institute of Molecular MedicineUniversity of Southern DenmarkOdenseDenmark

24. Division of GastroenterologyUniversity Hospital and University of IoanninaGreece

25. Hull University Teaching Hospitals NHS TrustHullUK

26. Hull York Medical SchoolHullUK

27. Department of GastroenterologyCentro Hospitalar de São João EPEPortoPortugal

28. Department of BiomedicinePorto UniversityPortoPortugal

29. Medical DepartmentThe National Hospital of the Faroe IslandsTorshavnFaroe Islands

30. Division of GastroenterologyUniversity of TartyTartuEstonia

31. Department of MedicineHerning Central HospitalHerningDenmark

32. Department of GastroenterologyLithuanian University of Health SciencesKaunasLithuania

33. Institute for Digestive ResearchLithuanian University of Health SciencesKaunasLithuania

34. Gastroenterology UnitAmiens University HospitalAmiensFrance

35. Public HealthEpidemiology and Economic HealthLille University and HospitalLilleFrance

36. Institute for Translational Research in Inflammation (Infinite)Lille UniversityLilleFrance

37. Private practiceNicosiaCyprus

38. Department of Gastroenterology and Liver DiseasesBen‐Gurion University of the NegevBeer ShevaIsrael

39. Department of Internal MedicineBen‐Gurion University of the NegevBeer ShevaIsrael

40. Department of Internal MedicineCsolnoky Ferenc Regional HospitalVeszpremHungary

41. 1st Department of MedicineSemmelweis UniversityBudapestHungary

42. Division of GastroenterologyMcGill University Health CenterMontrealCanada

43. Department of GastroenterologyHerlev HospitalUniversity of CopenhagenDenmark

Funder

Kirsten og Freddy Johansens Fond

Nordsjællands Hospital

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640620945949

Reference35 articles.

1. Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients

2. Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis

3. Aminosalicylates for induction of remission or response in Crohn’s disease;Lim W‐C;Cochrane Database Syst Rev,2016

4. Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn’s disease;Akobeng AK;Cochrane Database Syst Rev,2016

5. ECCO guidelines on therapeutics in Crohn’s disease: Medical treatment;Torres J;J Crohns Colitis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives;Gastrointestinal Disorders;2024-05-10

3. Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study;Inflammatory Bowel Diseases;2024-04-22

4. New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases;Therapeutic Advances in Gastroenterology;2024-01

5. Crohn's disease and clinical management today: How it does?;World Journal of Methodology;2023-12-20